Integrated Community Musculoskeletal and Pain Service

Where

Label

VI.3) Additional information

Section

Section VI

New Value

Old Value

Text

(for example if Mid and South Essex Integrated Care Board becomes a Greater Essex Integrated Care Board).

Where

Label

VI.3) Additional information

Section

Section VI

New Value

Text

and or the legal entity awarding the Contract

Old Value

Where

Label

II.2.4) Description of the procurement

Section

Section II

New Value

Text

This Prior Information Notice communicates NHS Mid and South Essex Integrated Care Board 's (the Authority) intention to undertake a competitive process in June 25 for provision of an Integrated Community Musculoskeletal and Pain Service (the Service), in accordance with the steps laid out in regulation 11 of the Health Care Services (Provider Selection Regime) Regulations 2023. Working with stakeholders since 2023, the Authority has developed a new community pathway for people aged 16 years+, based on the East of England Musculoskeletal (MSK) Pathway Improvement Framework, the Best MSK high impact recommendations and adhering to the Getting It Right First Time (GIRFT) pathway. This new model of care intends to provide integration across patient pathways, including Single Point of Access (SPoA), clinical triage, physiotherapy, orthopaedics, spinal, rheumatology, pain management, surgical interventions and therapies across MSE. It will assess and treat more patients outside of acute services and deliver improved outcomes, quality and patient experience of care. Estimated dates between which the service is intended to be provided: The Proposed Contract duration is five years from 2nd February 2026 until 1st February 2031, with an option to extend for a further three years beyond the initial term, until 1st February 2034. Approximate lifetime value of the contract: At the point of publication of this PIN, the Authority proposes a cost and volume financial model (local prices) in line with national guidance. The potential aggregate contract value (incl. extension term, growth/inflation assumptions, and potential variations) is £164,452,499 (excluding VAT). The financial envelope which will act as an affordability cap for the purposes of the competitive process will be £86,540,287 based on the initial 5-year contract term. These figures may be subject to change and any such changes will be made via Corrigendum. The Authority invites interested providers to attend a virtual engagement event, which will be broadcast via an Microsoft (MS) Teams Webinar on Monday 19th May 2025 at 1pm. Registration link: https://events.teams.microsoft.com/event/5118f90d-255e-4c7c-9d49-a04338a7127b@b5fa915c-fcb7-43a5-a5ad-631d989f6e1d The purpose of the market engagement event includes gauging market interest in the contract opportunity, providing information about the requirement to all interested providers, providing an understanding of how the competitive process will work (i.e. the process for raising clarification questions, declaring conflicts of interest, timescales etc), creating an open forum to discuss challenges / risks associated with the opportunity and obtaining feedback including finding out what information potential bidders might require to submit compliant and meaningful tenders. There is currently no anticipated limit on the number of attendees per organisation that can register for the event. The ICB presentation will last for up to 30 mins, followed by a Q&A session for up to 30 minutes. The recording of the webinar will be available shortly after the event itself. All individuals who are interested in attending must register individually via the registration link provided, which will send a joining link by email to each individual. When attendees join the meeting their video and mic will be turned off by default, and names will be hidden from other participants, but not the Organisers. All questions need to be asked via the Q&A chat function which attendees will have access to throughout the meeting itself, but questions will not be reviewed and responded until the end of the presentation. Any queries regarding the market engagement event and or the future Competitive Process should be directed via the messaging facility in the Portal for project reference: sq_125 - Market Engagement Event - Integrated Community Musculoskeletal and Pain Service which can be accessed here: https://attain.bravosolution.co.uk/

Old Value

Text

This Prior Information Notice communicates NHS Mid and South Essex Integrated Care Board 's (the Authority) intention to undertake a competitive process in June 25 for provision of an Integrated Community Musculoskeletal and Pain Service (the Service), in accordance with the steps laid out in regulation 11 of the Health Care Services (Provider Selection Regime) Regulations 2023. Working with stakeholders since 2023, the Authority has developed a new community pathway for people aged 16 years+, based on the East of England Musculoskeletal (MSK) Pathway Improvement Framework, the Best MSK high impact recommendations and adhering to the Getting It Right First Time (GIRFT) pathway. This new model of care intends to provide integration across patient pathways, including Single Point of Access (SPoA), clinical triage, physiotherapy, orthopaedics, spinal, rheumatology, pain management, surgical interventions and therapies across MSE. It will assess and treat more patients outside of acute services and deliver improved outcomes, quality and patient experience of care. Estimated dates between which the service is intended to be provided: The Proposed Contract duration is five years from 2nd February 2026 until 1st February 2031, with an option to extend for a further three years beyond the initial term, until 1st February 2034. Approximate lifetime value of the contract: At the point of publication of this PIN, the Authority proposes a cost and volume financial model (local prices) in line with national guidance. The potential aggregate contract value (incl. extension term, growth/inflation assumptions, and potential variations) is £164,452,499 (excluding VAT). The financial envelope which will act as an affordability cap for the purposes of the competitive process will be £86,540,287 based on the initial 5-year contract term. The Authority intends to hold a market engagement event relating to this requirement to inform the procurement approach. If any information within this Notice changes as a result of activity associated with the market engagement and or procurement strategy development between publication of this PIN, and the Contract Notice inviting offers being published, the Contract Notice will contain the updated information that will supersede that which is contained within this PIN. It is anticipated that the market engagement event will occur between 19th and 23rd May 2025 but this has not been finalised at time of publication of this PIN. Further details regarding the event (including the date and time and how to register), will be issued around 6th May, via corrigendum to this PIN. Any queries regarding the market engagement event and or the future Competitive Process should be directed to the Named Contact in this Notice and the email address provided herein.

Where

Label

VI.3) Additional information

Section

Section VI

New Value

Text

and or the legal entity awarding the Contract

Old Value

Where

Label

II.2.4) Description of the procurement

Section

Section II

New Value

Text

This Prior Information Notice communicates NHS Mid and South Essex Integrated Care Board 's (the Authority) intention to undertake a competitive process in June 25 for provision of an Integrated Community Musculoskeletal and Pain Service (the Service), in accordance with the steps laid out in regulation 11 of the Health Care Services (Provider Selection Regime) Regulations 2023. Working with stakeholders since 2023, the Authority has developed a new community pathway for people aged 16 years+, based on the East of England Musculoskeletal (MSK) Pathway Improvement Framework, the Best MSK high impact recommendations and adhering to the Getting It Right First Time (GIRFT) pathway. This new model of care intends to provide integration across patient pathways, including Single Point of Access (SPoA), clinical triage, physiotherapy, orthopaedics, spinal, rheumatology, pain management, surgical interventions and therapies across MSE. It will assess and treat more patients outside of acute services and deliver improved outcomes, quality and patient experience of care. Estimated dates between which the service is intended to be provided: The Proposed Contract duration is five years from 2nd February 2026 until 1st February 2031, with an option to extend for a further three years beyond the initial term, until 1st February 2034. Approximate lifetime value of the contract: At the point of publication of this PIN, the Authority proposes a cost and volume financial model (local prices) in line with national guidance. The potential aggregate contract value (incl. extension term, growth/inflation assumptions, and potential variations) is 164,149,073 (excluding VAT). The financial envelope which will act as an affordability cap for the purposes of the competitive process will be £90,163,317 based on the initial 5-year contract term. The Authority invites interested providers to attend a virtual engagement event, which will be broadcast via an Microsoft (MS) Teams Webinar on Monday 19th May 2025 at 1pm. Registration link: https://events.teams.microsoft.com/event/5118f90d-255e-4c7c-9d49-a04338a7127b@b5fa915c-fcb7-43a5-a5ad-631d989f6e1d The purpose of the market engagement event includes gauging market interest in the contract opportunity, providing information about the requirement to all interested providers, providing an understanding of how the competitive process will work (i.e. the process for raising clarification questions, declaring conflicts of interest, timescales etc), creating an open forum to discuss challenges / risks associated with the opportunity and obtaining feedback including finding out what information potential bidders might require to submit compliant and meaningful tenders. There is currently no anticipated limit on the number of attendees per organisation that can register for the event. The ICB presentation will last for up to 30 mins, followed by a Q&A session for up to 30 minutes. The recording of the webinar will be available shortly after the event itself. All individuals who are interested in attending must register individually via the registration link provided, which will send a joining link by email to each individual. When attendees join the meeting their video and mic will be turned off by default, and names will be hidden from other participants, but not the Organisers. All questions need to be asked via the Q&A chat function which attendees will have access to throughout the meeting itself, but questions will not be reviewed and responded until the end of the presentation. Any queries regarding the market engagement event and or the future Competitive Process should be directed via the messaging facility in the Portal for project reference: sq_125 - Market Engagement Event - Integrated Community Musculoskeletal and Pain Service which can be accessed here: https://attain.bravosolution.co.uk/

Old Value

Text

This Prior Information Notice communicates NHS Mid and South Essex Integrated Care Board 's (the Authority) intention to undertake a competitive process in June 25 for provision of an Integrated Community Musculoskeletal and Pain Service (the Service), in accordance with the steps laid out in regulation 11 of the Health Care Services (Provider Selection Regime) Regulations 2023. Working with stakeholders since 2023, the Authority has developed a new community pathway for people aged 16 years+, based on the East of England Musculoskeletal (MSK) Pathway Improvement Framework, the Best MSK high impact recommendations and adhering to the Getting It Right First Time (GIRFT) pathway. This new model of care intends to provide integration across patient pathways, including Single Point of Access (SPoA), clinical triage, physiotherapy, orthopaedics, spinal, rheumatology, pain management, surgical interventions and therapies across MSE. It will assess and treat more patients outside of acute services and deliver improved outcomes, quality and patient experience of care. Estimated dates between which the service is intended to be provided: The Proposed Contract duration is five years from 2nd February 2026 until 1st February 2031, with an option to extend for a further three years beyond the initial term, until 1st February 2034. Approximate lifetime value of the contract: At the point of publication of this PIN, the Authority proposes a cost and volume financial model (local prices) in line with national guidance. The potential aggregate contract value (incl. extension term, growth/inflation assumptions, and potential variations) is £164,452,499 (excluding VAT). The financial envelope which will act as an affordability cap for the purposes of the competitive process will be £86,540,287 based on the initial 5-year contract term. These figures may be subject to change and any such changes will be made via Corrigendum. The Authority invites interested providers to attend a virtual engagement event, which will be broadcast via an Microsoft (MS) Teams Webinar on Monday 19th May 2025 at 1pm. Registration link: https://events.teams.microsoft.com/event/5118f90d-255e-4c7c-9d49-a04338a7127b@b5fa915c-fcb7-43a5-a5ad-631d989f6e1d The purpose of the market engagement event includes gauging market interest in the contract opportunity, providing information about the requirement to all interested providers, providing an understanding of how the competitive process will work (i.e. the process for raising clarification questions, declaring conflicts of interest, timescales etc), creating an open forum to discuss challenges / risks associated with the opportunity and obtaining feedback including finding out what information potential bidders might require to submit compliant and meaningful tenders. There is currently no anticipated limit on the number of attendees per organisation that can register for the event. The ICB presentation will last for up to 30 mins, followed by a Q&A session for up to 30 minutes. The recording of the webinar will be available shortly after the event itself. All individuals who are interested in attending must register individually via the registration link provided, which will send a joining link by email to each individual. When attendees join the meeting their video and mic will be turned off by default, and names will be hidden from other participants, but not the Organisers. All questions need to be asked via the Q&A chat function which attendees will have access to throughout the meeting itself, but questions will not be reviewed and responded until the end of the presentation. Any queries regarding the market engagement event and or the future Competitive Process should be directed via the messaging facility in the Portal for project reference: sq_125 - Market Engagement Event - Integrated Community Musculoskeletal and Pain Service which can be accessed here: https://attain.bravosolution.co.uk/

Where

Label

VI.3) Additional information

Section

Section VI

New Value

Text

and or the legal entity awarding the Contract

Old Value

Where

Label

II.2.4) Description of the procurement

Section

Section II

New Value

Text

The Authority is undertaking this competitive process under the Health Care Services (Provider Selection Regime) Regulations 2023 (the Regulations) to award the Proposed Contract for the Integrated Community Musculoskeletal and Pain Service (the Service). Working with stakeholders since 2023, the Authority has developed a new community pathway for people aged 16 years+, based on the East of England Musculoskeletal (MSK) Pathway Improvement Framework, the Best MSK high impact recommendations and adhering to the Getting It Right First Time (GIRFT) pathway. This new model of care intends to provide integration across patient pathways, including Single Point of Access (SPoA), clinical triage, physiotherapy, orthopaedics, spinal, rheumatology, pain management, surgical interventions and therapies across MSE. It will assess and treat more patients outside of acute services and deliver improved outcomes, quality and patient experience of care. Estimated dates between which the service is intended to be provided: The Proposed Contract duration is five years from 1st February 2026 until 31st January 2031, with an option to extend for a further three years beyond the initial term, until 31st January 2034. Approximate lifetime value of the contract: At the point of publication of this PIN, the Authority proposes a cost and volume financial model (local prices) in line with national guidance. The potential aggregate contract value (incl. extension term, growth/inflation assumptions, and potential variations) is £165,210,325 (excluding VAT). The financial envelope which will act as an affordability cap for the purposes of the competitive process will be £90,749,348 based on the initial 5-year contract term. The Proposed Contract to be entered into by the Authority and the Preferred Bidder(s) for the Services will be based on the NHS Standard Contract 2025/26 (full-length) and all subsequent variations thereof from time to time during the contract term. Further information can be found at VI.3 and in the Process documents available from https://attain.bravosolution.co.uk/.

Old Value

Text

The Authority is undertaking this competitive process under the Health Care Services (Provider Selection Regime) Regulations 2023 (the Regulations) to award the Proposed Contract for the Integrated Community Musculoskeletal and Pain Service (the Service). Working with stakeholders since 2023, the Authority has developed a new community pathway for people aged 16 years+, based on the East of England Musculoskeletal (MSK) Pathway Improvement Framework, the Best MSK high impact recommendations and adhering to the Getting It Right First Time (GIRFT) pathway. This new model of care intends to provide integration across patient pathways, including Single Point of Access (SPoA), clinical triage, physiotherapy, orthopaedics, spinal, rheumatology, pain management, surgical interventions and therapies across MSE. It will assess and treat more patients outside of acute services and deliver improved outcomes, quality and patient experience of care. Estimated dates between which the service is intended to be provided: The Proposed Contract duration is five years from 1st February 2026 until 31st January 2031, with an option to extend for a further three years beyond the initial term, until 31st January 2034. Approximate lifetime value of the contract: At the point of publication of this PIN, the Authority proposes a cost and volume financial model (local prices) in line with national guidance. The potential aggregate contract value (incl. extension term, growth/inflation assumptions, and potential variations) is £164,149,073 (excluding VAT). The financial envelope which will act as an affordability cap for the purposes of the competitive process will be £90,163,317 based on the initial 5-year contract term. The Proposed Contract to be entered into by the Authority and the Preferred Bidder(s) for the Services will be based on the NHS Standard Contract 2025/26 (full-length) and all subsequent variations thereof from time to time during the contract term. Further information can be found at VI.3 and in the Process documents available from https://attain.bravosolution.co.uk/.

Where

Label

II.2.4) Description of the procurement

Section

Section II

New Value

Text

The Authority is undertaking this competitive process under the Health Care Services (Provider Selection Regime) Regulations 2023 (the Regulations) to award the Proposed Contract for the Integrated Community Musculoskeletal and Pain Service (the Service). Working with stakeholders since 2023, the Authority has developed a new community pathway for people aged 16 years+, based on the East of England Musculoskeletal (MSK) Pathway Improvement Framework, the Best MSK high impact recommendations and adhering to the Getting It Right First Time (GIRFT) pathway. This new model of care intends to provide integration across patient pathways, including Single Point of Access (SPoA), clinical triage, physiotherapy, orthopaedics, spinal, rheumatology, pain management, surgical interventions and therapies across MSE. It will assess and treat more patients outside of acute services and deliver improved outcomes, quality and patient experience of care. Estimated dates between which the service is intended to be provided: The Proposed Contract duration is five years from 1st February 2026 until 31st January 2031, with an option to extend for a further three years beyond the initial term, until 31st January 2034. Approximate lifetime value of the contract: At the point of publication of this PIN, the Authority proposes a cost and volume financial model (local prices) in line with national guidance. The potential aggregate contract value (incl. extension term, growth/inflation assumptions, and potential variations) is £165,210,325 (excluding VAT). The financial envelope which will act as an affordability cap for the purposes of the competitive process will be £90,749,348 based on the initial 5-year contract term. The Proposed Contract to be entered into by the Authority and the Preferred Bidder(s) for the Services will be based on the NHS Standard Contract 2025/26 (full-length) and all subsequent variations thereof from time to time during the contract term. Further information can be found at VI.3 and in the Process documents available from https://attain.bravosolution.co.uk/.

Old Value

Text

The Authority is undertaking this competitive process under the Health Care Services (Provider Selection Regime) Regulations 2023 (the Regulations) to award the Proposed Contract for the Integrated Community Musculoskeletal and Pain Service (the Service). Working with stakeholders since 2023, the Authority has developed a new community pathway for people aged 16 years+, based on the East of England Musculoskeletal (MSK) Pathway Improvement Framework, the Best MSK high impact recommendations and adhering to the Getting It Right First Time (GIRFT) pathway. This new model of care intends to provide integration across patient pathways, including Single Point of Access (SPoA), clinical triage, physiotherapy, orthopaedics, spinal, rheumatology, pain management, surgical interventions and therapies across MSE. It will assess and treat more patients outside of acute services and deliver improved outcomes, quality and patient experience of care. Estimated dates between which the service is intended to be provided: The Proposed Contract duration is five years from 1st February 2026 until 31st January 2031, with an option to extend for a further three years beyond the initial term, until 31st January 2034. Approximate lifetime value of the contract: At the point of publication of this PIN, the Authority proposes a cost and volume financial model (local prices) in line with national guidance. The potential aggregate contract value (incl. extension term, growth/inflation assumptions, and potential variations) is £164,149,073 (excluding VAT). The financial envelope which will act as an affordability cap for the purposes of the competitive process will be £90,163,317 based on the initial 5-year contract term. The Proposed Contract to be entered into by the Authority and the Preferred Bidder(s) for the Services will be based on the NHS Standard Contract 2025/26 (full-length) and all subsequent variations thereof from time to time during the contract term. Further information can be found at VI.3 and in the Process documents available from https://attain.bravosolution.co.uk/.

Where

Label

II.2.6) Estimated value

Section

Section II

New Value

Text

Value excluding VAT: £165,210,345

Old Value

Text

Value excluding VAT: £164,149,073

Where

Label

II.1.4) Short description

Section

Section II

New Value

Text

This is a Contract Award Notice communicating NHS Mid and South Essex Integrated Care Board's award of a public contract for provision of an Integrated Community Musculoskeletal and Pain Service (the Service), in accordance with the steps laid out in regulation 11 of the Health Care Services (Provider Selection Regime) Regulations 2023. Estimated dates between which the service is intended to be provided: The Proposed Contract duration is five years from 1st February 2026 until 31st January 2031, with an option to extend for a further three years beyond the initial term, until 31st January 2034.

Old Value

Text

This is a Contract Award Notice (Intention to Award) communicating NHS Mid and South Essex Integrated Care Board 's intention to award a public contract for provision of an Integrated Community Musculoskeletal and Pain Service (the Service), in accordance with the steps laid out in regulation 11 of the Health Care Services (Provider Selection Regime) Regulations 2023. Estimated dates between which the service is intended to be provided: The Proposed Contract duration is five years from 1st February 2026 until 31st January 2031, with an option to extend for a further three years beyond the initial term, until 31st January 2034.

Where

Label

II.2.4) Description of the procurement

Section

Section II

New Value

Text

The Authority has undertaken a competitive process under the Health Care Services (Provider Selection Regime) Regulations 2023 (the Regulations) and has awarded the Proposed Contract for a new Integrated Community Musculoskeletal and Pain Service (the Service) to the Preferred Bidder identified through the process, Cora Health MSK Limited. Working with stakeholders since 2023, the Authority has developed a new community pathway for people aged 16 years+, based on the East of England Musculoskeletal (MSK) Pathway Improvement Framework, the Best MSK high impact recommendations and adhering to the Getting It Right First Time (GIRFT) pathway. This new model of care intends to provide integration across patient pathways, including Single Point of Access (SPoA), clinical triage, physiotherapy, orthopaedics, spinal, rheumatology, pain management, surgical interventions and therapies across MSE. It will assess and treat more patients outside of acute services and deliver improved outcomes, quality and patient experience of care. Estimated dates between which the service is intended to be provided: The Proposed Contract duration is five years from 1st February 2026 until 31st January 2031, with an option to extend for a further three years beyond the initial term, until 31st January 2034. Approximate lifetime value of the contract: At the point of publication of the PIN, the Authority proposed a cost and volume financial model (local prices) in line with national guidance. The potential aggregate contract value (incl. extension term, growth/inflation assumptions, and potential variations) was £164,149,073 (excluding VAT). The financial envelope which acted as an affordability cap for the purposes of the competitive process was £90,163,317 based on the initial 5-year contract term. The Proposed Contract for the first five years has been awarded at £84,392,517.55. The Proposed Contract to be entered into by the Authority and the Preferred Bidder and a back to back version thereof with its proposed Sub-Contractor (both of which are existing providers of MSK Services in mid and south Essex), will be based on the NHS Standard Contract 2025/26 (full-length) and all subsequent variations thereof from time to time during the contract term.

Old Value

Text

The Authority has undertaken a competitive process under the Health Care Services (Provider Selection Regime) Regulations 2023 (the Regulations) and intends to award the Proposed Contract for a new Integrated Community Musculoskeletal and Pain Service (the Service) to the Preferred Bidder identified through the process, Cora Health MSK Limited. Working with stakeholders since 2023, the Authority has developed a new community pathway for people aged 16 years+, based on the East of England Musculoskeletal (MSK) Pathway Improvement Framework, the Best MSK high impact recommendations and adhering to the Getting It Right First Time (GIRFT) pathway. This new model of care intends to provide integration across patient pathways, including Single Point of Access (SPoA), clinical triage, physiotherapy, orthopaedics, spinal, rheumatology, pain management, surgical interventions and therapies across MSE. It will assess and treat more patients outside of acute services and deliver improved outcomes, quality and patient experience of care. Estimated dates between which the service is intended to be provided: The Proposed Contract duration is five years from 1st February 2026 until 31st January 2031, with an option to extend for a further three years beyond the initial term, until 31st January 2034. Approximate lifetime value of the contract: At the point of publication of the PIN, the Authority proposed a cost and volume financial model (local prices) in line with national guidance. The potential aggregate contract value (incl. extension term, growth/inflation assumptions, and potential variations) was £164,149,073 (excluding VAT). The financial envelope which acted as an affordability cap for the purposes of the competitive process was £90,163,317 based on the initial 5-year contract term. The Proposed Contract for the first five years has been awarded at £84,392,517.55. The Proposed Contract to be entered into by the Authority and the Preferred Bidder and a back to back version thereof with its proposed Sub-Contractor (both of which are existing providers of MSK Services in mid and south Essex), will be based on the NHS Standard Contract 2025/26 (full-length) and all subsequent variations thereof from time to time during the contract term.

Where

Label

VI.4.3) Review procedure

Section

Section VI

New Value

Text

The standstill period requirements, including for review of decisions, are detailed in Regulations 12 and 14(3). Representations should be made by midnight on 2nd October latest. Provision for independent expert advice is set out in Regulation 23, including how the Independent Patient Choice and Procurement Panel may provide advice during the standstill period. Where Representations are received by 2ns October, initial reviews will be undertaken by the Authority via an appropriate internal governance mechanism that has been established to deal with representations made against provider selection decisions. The Authority will follow the relevant transparency requirements for the approach they take and will keep internal records of their decision-making. Where a provider(s) requests a further review by the Independent Patient Choice and Procurement Panel (within 5 working days of the Authority' publication of it's Further Decision) they should seek relevant advice via the contact details provided herein at VI.4.4.

Old Value

Text

The standstill period requirements, including for review of decisions, are detailed in Regulations 12 and 14(3). Representations should be made by midnight on 2nd October latest. Provision for independent expert advice is set out in Regulation 23, including how the Independent Patient Choice and Procurement Panel may provide advice during the standstill period. Where Representations are received by 2ns October, initial reviews will be undertaken by the Authority via an appropriate internal governance mechanism that has been established to deal with representations made against provider selection decisions. The Authority will follow the relevant transparency requirements for the approach they take and will keep internal records of their decision-making. Where a provider(s) requests a further review by the Independent Patient Choice and Procurement Panel (within 5 working days of the Authority' publication of its Further Decision) they should seek relevant advice via the contact details provided herein at VI.4.4.